Transaction in Own Shares

Summary by AI BETAClose X

On September 30, 2025, GSK plc, acting through BNP Paribas SA, purchased 305,000 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought at prices ranging from 1,521.00p to 1,591.00p per share, with a volume-weighted average price of 1,548.83p. These shares will be held as treasury shares as part of the company's existing buyback program. Following this purchase, GSK holds 247,769,844 ordinary shares in treasury and has 4,067,637,496 ordinary shares in issue, excluding treasury shares; the total number of voting rights in the Company is 4,067,637,496, and the percentage of voting rights attributable to ordinary shares held in treasury is 6.09 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings